BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Zois CD, Baltayiannis GH, Bekiari A, Goussia A, Karayiannis P, Doukas M, Demopoulos D, Mitsellou A, Vougiouklakis T, Mitsi V, Tsianos EV. Steatosis and steatohepatitis in postmortem material from Northwestern Greece. World J Gastroenterol 2010; 16(31): 3944-3949 [PMID: 20712056 DOI: 10.3748/wjg.v16.i31.3944]
URL: https://www.wjgnet.com/1007-9327/full/v16/i31/3944.htm
(0) (0) (6030) (47)
Number Citing Articles
1
Verena C. Obmann, Nando Mertineit, Annalisa Berzigotti, Christina Marx, Lukas Ebner, Roland Kreis, Peter Vermathen, Johannes T. Heverhagen, Andreas Christe, Adrian T. Huber, Gianfranco D. Alpini. CT predicts liver fibrosis: Prospective evaluation of morphology- and attenuation-based quantitative scores in routine portal venous abdominal scans. PLOS ONE 2018; 13(7) doi: 10.1371/journal.pone.0199611
2
Evangelos Chartampilas. Imaging of nonalcoholic fatty liver disease and its clinical utility. Hormones 2018; 17(1) doi: 10.1007/s42000-018-0012-x
3
Levent Doganay, Kamil Ozdil, Mehmet Sokmen. Last Blood Check Before Passing: Does Alcohol Prevent Fibrosis?. American Journal of Gastroenterology 2013; 108(6) doi: 10.1038/ajg.2013.74
4
Katharina Cichon, Corinna A. Schön. Influences on the amount of intraperitoneal haemorrhage after blunt liver injury. European Journal of Gastroenterology & Hepatology 2012;  doi: 10.1097/MEG.0b013e3283579445
5
D. Kreul, D. Gascho, S. Franckenberg, S. Eggert, B. Fliss, R.A. Kubik-Huch, M.J. Thali, T. Niemann. Postmortem determination of hepatic steatosis. Comparing Rho/Z and fat fraction measurements on dual-energy CT for histological grading: A retrospective analysis. Forensic Imaging 2020; 23 doi: 10.1016/j.fri.2020.200422
6
Amreen Dinani, Norman Sussman, Mazen Noureddin, Michael Fuchs, George Therapondos, Nigel Girgrah, Viviana Figueroa Diaz, Parvez Mantry, Mary Rinella, Amon Asgharpour, Douglas Dieterich. An algorithm for the management of non-alcoholic fatty liver disease in primary care. Gastroenterology & Hepatology: Open Access 2021; 12(4) doi: 10.15406/ghoa.2021.12.00469
7
Stefano Bellentani. The epidemiology of non‐alcoholic fatty liver disease. Liver International 2017; 37(S1) doi: 10.1111/liv.13299
8
Kira Bettermann, Tabea Hohensee, Johannes Haybaeck. Steatosis and Steatohepatitis: Complex Disorders. International Journal of Molecular Sciences 2014; 15(6) doi: 10.3390/ijms15069924
9
Jia Xiao, George L. Tipoe. Lycium Barbarum and Human Health. 2015;  doi: 10.1007/978-94-017-9658-3_3
10
Mehmet Sayiner, Aaron Koenig, Linda Henry, Zobair M. Younossi. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World. Clinics in Liver Disease 2016; 20(2) doi: 10.1016/j.cld.2015.10.001
11
Gabriela S. de Castro, Philip C. Calder. Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids. Clinical Nutrition 2018; 37(1) doi: 10.1016/j.clnu.2017.01.006
12
Yuri Hirayama, Natasha Faye Daniels, Shelley Evans, David Clarke, Stephenie Purvis, Charlotte Oliver, Stephen Woodmansey, Joy Staniforth, Elizabeth J. Soilleux. High Prevalence of Pre-Existing Liver Abnormalities Identified Via Autopsies in COVID-19: Identification of a New Silent Risk Factor?. Diagnostics 2021; 11(9) doi: 10.3390/diagnostics11091703
13
Soo Lim, Tae Jung Oh, Kwang Kon Koh. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders. International Journal of Cardiology 2015; 201 doi: 10.1016/j.ijcard.2015.08.107
14
Eirini Siafi, Ioannis Andrikou, Dimitris Konstantinidis, Niki Kakouri, Panagiotis Iliakis, John Koskinas, Emmanouil Koullias, Eleftherios Thireos, Dimitris Tousoulis, Costas Thomopoulos, Costas Tsioufis. Fatty liver index and hypertension-mediated organ damage in never-treated hypertensive patients without diabetes mellitus. Journal of Hypertension 2021; 39(12) doi: 10.1097/HJH.0000000000002954
15
Katharina Staufer, Ursula Huber-Schönauer, Georg Strebinger, Philipp Pimingstorfer, Silke Suesse, Thomas-Matthias Scherzer, Bernhard Paulweber, Peter Ferenci, Thomas Stimpfl, Michel Yegles, Christian Datz, Michael Trauner. Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease. Journal of Hepatology 2022; 77(4) doi: 10.1016/j.jhep.2022.04.040
16
Zobair M. Younossi. Non-alcoholic fatty liver disease – A global public health perspective. Journal of Hepatology 2019; 70(3) doi: 10.1016/j.jhep.2018.10.033
17
G. Vernon, A. Baranova, Z. M. Younossi. Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults. Alimentary Pharmacology & Therapeutics 2011; 34(3) doi: 10.1111/j.1365-2036.2011.04724.x
18
Filippo Procino, Giovanni Misciagna, Nicola Veronese, Maria G. Caruso, Marisa Chiloiro, Anna M. Cisternino, Maria Notarnicola, Caterina Bonfiglio, Irene Bruno, Claudia Buongiorno, Angelo Campanella, Valentina Deflorio, Isabella Franco, Rocco Guerra, Carla M. Leone, Antonella Mirizzi, Alessandro Nitti, Alberto R. Osella. Reducing NAFLD‐screening time: A comparative study of eight diagnostic methods offering an alternative to ultrasound scans. Liver International 2019; 39(1) doi: 10.1111/liv.13970
19
Noa Mashav, Oren Shibolet. Liver Metabolism and Fatty Liver Disease. Oxidative Stress and Disease 2014; 20144564 doi: 10.1201/b17315-3
20
Eline H. van den Berg, Marzyeh Amini, Tim C. M. A. Schreuder, Robin P. F. Dullaart, Klaas Nico Faber, Behrooz Z. Alizadeh, Hans Blokzijl, Salvatore Petta. Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort. PLOS ONE 2017; 12(2) doi: 10.1371/journal.pone.0171502
21
Stergios A. Polyzos, Jannis Kountouras, Athanasios Papatheodorou, Kalliopi Patsiaoura, Evangelia Katsiki, Efthimia Zafeiriadou, Christos Zavos, Kyriaki Anastasiadou, Evangelos Terpos. Helicobacter pylori infection in patients with nonalcoholic fatty liver disease. Metabolism 2013; 62(1) doi: 10.1016/j.metabol.2012.06.007
22
Christopher M. Milroy. Fatty Liver and the Forensic Pathologist. Academic Forensic Pathology 2018; 8(2) doi: 10.1177/1925362118782061
23
Paulo Reis-Júnior, Ryan Tanigawa, Gustavo Heluani Antunes de Mesquita, Natalia Basan, Venâncio Alves, Luiz Augusto Carneiro D'Albuquerque, Wellington Andraus. Steatosis and steatohepatitis found in adults after death due to non-burn trauma. Clinics 2019; 74 doi: 10.6061/clinics/2019/e1070
24
Pedro M. Rodrigues, Ainhoa Lapitz, André L. Simão, Maria J. Perugorria, Marco Arrese, Rui E. Castro, Jesus M. Banales. NAFLD and NASH. 2020;  doi: 10.1007/978-3-030-37173-9_9
25
Süleyman GÜNAY, Zehra Betül PAKÖZ, Haydar ADANIR. Evaluation of C-reactive protein levels in the differentiation of non-alcoholic steatohepatitis and simple liver steatosis. Akdeniz Medical Journal 2022;  doi: 10.53394/akd.976570
26
Zaki A. Sherif, Armana Saeed, Shima Ghavimi, Seyed-Mehdi Nouraie, Adeyinka O. Laiyemo, Hassan Brim, Hassan Ashktorab. Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations. Digestive Diseases and Sciences 2016; 61(5) doi: 10.1007/s10620-016-4143-0
27
Sim Y. Ong, Amanda J. Nicoll, Martin B. Delatycki. How should hyperferritinaemia be investigated and managed?. European Journal of Internal Medicine 2016; 33 doi: 10.1016/j.ejim.2016.05.014
28
Kiran Gangadhar, Kedar N. Chintapalli, Gilbert Cortez, Sandhya Vinu Nair. MRI evaluation of fatty liver in day to day practice: Quantitative and qualitative methods. The Egyptian Journal of Radiology and Nuclear Medicine 2014; 45(3) doi: 10.1016/j.ejrnm.2014.05.015
29
Linda Henry, James Paik, Zobair M. Younossi. Review article: the epidemiologic burden of non‐alcoholic fatty liver disease across the world. Alimentary Pharmacology & Therapeutics 2022; 56(6) doi: 10.1111/apt.17158
30
Bo Kyung Koo, Soo Lim. Clinical Obesity in Adults and Children. 2022;  doi: 10.1002/9781119695257.ch13
31
Stergios A. Polyzos, Jannis Kountouras, Aristeidis Slavakis, Efthimia Zafeiriadou, Kalliopi Patsiaoura, Evangelia Katsiki, Christos Zavos, Athanasios Papatheodorou, Evangelos Terpos. A novel noninvasive index for nonalcoholic steatohepatitis: a pilot study. Biomarkers 2013; 18(7) doi: 10.3109/1354750X.2013.838305
32
Benedetta Campana, David Semela, Markus Heim, Christine Bernsmeier. Non-Alcoholic Fatty Liver Disease – Changing the Prevalence of Liver Cancer?. EMJ Hepatology 2015;  doi: 10.33590/emjhepatol/10314903
33
Abhijit Chowdhury, Zobair M. Younossi. Alcoholic and Non-Alcoholic Fatty Liver Disease. 2016;  doi: 10.1007/978-3-319-20538-0_2
34
Georgios Sfikas, Michael Psallas, Charalambos Koumaras, Konstantinos Imprialos, Evangelos Perdikakis, Michael Doumas, Olga Giouleme, Asterios Karagiannis, Vasilios G. Athyros. Prevalence, Diagnosis, and Treatment with 3 Different Statins of Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?. Current Vascular Pharmacology 2021; 19(5) doi: 10.2174/1570161118666201015152921
35
Bubu A. Banini, Arun J. Sanyal. Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options. Clinical Medicine Insights: Therapeutics 2016; 8 doi: 10.4137/CMT.S18885
36
Shahid Habib. Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtyping. World Journal of Gastrointestinal Pathophysiology 2024; 15(2): 92791 doi: 10.4291/wjgp.v15.i2.92791
37
Martin Blachier, Henri Leleu, Markus Peck-Radosavljevic, Dominique-Charles Valla, Françoise Roudot-Thoraval. The burden of liver disease in Europe: A review of available epidemiological data. Journal of Hepatology 2013; 58(3) doi: 10.1016/j.jhep.2012.12.005
38
Niki S. Kakouri, Costas G. Thomopoulos, Eirini P. Siafi, Angeliki E. Valatsou, Kyriakos S. Dimitriadis, Iliana P. Mani, Sotirios P. Patsilinakos, Dimitrios M. Tousoulis, Konstantinos P. Tsioufis. Overview of the Association Between Non-Alcoholic Fatty Liver Disease and Hypertension. Cardiology Discovery 2024; 4(1) doi: 10.1097/CD9.0000000000000113
39
Winston Dunn, Zhen Zeng, Maura O'Neil, Jie Zhao, Melissa Whitener, Yu-Jui Y Wan, Erik K Mitchell, Michael Handler, Steven A Weinman. The Interaction of rs738409, Obesity, and Alcohol: A Population-Based Autopsy Study. American Journal of Gastroenterology 2012; 107(11) doi: 10.1038/ajg.2012.285
40
Zobair Younossi, Quentin M. Anstee, Milena Marietti, Timothy Hardy, Linda Henry, Mohammed Eslam, Jacob George, Elisabetta Bugianesi. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nature Reviews Gastroenterology & Hepatology 2018; 15(1) doi: 10.1038/nrgastro.2017.109
41
Mark D. Muthiah, Arun J. Sanyal. Burden of Disease due to Nonalcoholic Fatty Liver Disease. Gastroenterology Clinics of North America 2020; 49(1) doi: 10.1016/j.gtc.2019.09.007
42
Ilkay Ergenc, Erdogan Kara, Muhammed Emre Yilmaz, Coskun Ozer Demirtas, Caglayan Keklikkiran, Taner Das, Yalcin Buyuk, Cigdem Celikel, Hizir Asliyuksek, Yusuf Yilmaz. Prevalence of metabolic dysfunction-associated steatotic liver disease and steatohepatitis in Türkiye: A forensic autopsy study. Heliyon 2024; 10(15) doi: 10.1016/j.heliyon.2024.e34915
43
Soo Lim, Marja‐Riitta Taskinen, Jan Borén. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome. Obesity Reviews 2019; 20(4) doi: 10.1111/obr.12820
44
Chandra Prakash Saini, Satinder Pal Singh, Kuldip Kumar, Permeet Kaur Bagga, Harsh Kumar, Mandeep Rai. An Autopsy-Based Comparative Study on Alcohol-Related Versus Non-Alcohol-Related Liver Pathologies. Journal of Punjab Academy of Forensic Medicine & Toxicology 2025; 25(2) doi: 10.5958/0974-083X.2025.00038.7
45
Aitana Braza‐Boïls, Josep Marí‐Alexandre, Pilar Molina, Miguel A. Arnau, Moisés Barceló‐Molina, Diana Domingo, Javier Girbes, Juan Giner, Luis Martínez‐Dolz, Esther Zorio. Deregulated hepatic microRNAs underlie the association between non‐alcoholic fatty liver disease and coronary artery disease. Liver International 2016; 36(8) doi: 10.1111/liv.13097
46
Huilong Chen, Yuan Zhan, Jinxiang Zhang, Sheng Cheng, Yuhao Zhou, Liyuan Chen, Zhilin Zeng. The Global, Regional, and National Burden and Trends of NAFLD in 204 Countries and Territories: An Analysis From Global Burden of Disease 2019. JMIR Public Health and Surveillance 2022; 8(12) doi: 10.2196/34809
47
Soo Lim. Clinical Dilemmas in Non‐Alcoholic Fatty Liver Disease. 2016;  doi: 10.1002/9781118924938.ch12
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.